This report is Lovesac’s fourth annual ESG report and is part of the Company’s multi-phased ESG commitment to serve its customers, associates, communities, suppliers, and stakeholders in a way that ...
Syndax Pharmaceuticals has announced the elimination of the Chief Medical Officer position, resulting in Catherine Madigan, M.D. departing from the company. This organizational change may impact ...
Conduit Pharmaceuticals ( ) has issued an announcement. Conduit Pharmaceuticals Inc. has been notified by Nasdaq of its non-compliance with the listing rule due to its stock price ...